Blog

  • The Microbiome

    The Microbiome

    The microbiome market is on fire. The hype is evident with new companies, investments, big pharma collaborations, and acquisitions. Funding has reached a historic level of close to 2 billion dollars worldwide (2020). Pharma companies such as Takeda, Gilead, DuPont, GSK, Pfizer, and Merck have entered significant collaboration deals with Microbiome biotech companies. This impressive […]

  • Bacteriophages: A Promising Therapeutic Tool

    Bacteriophages: A Promising Therapeutic Tool

    Microbiome engineers are seeking tools that are specific enough to home in on the bacterial population of interest with uncompromised precision. That is exactly the promise behind bacteriophages. Bacteriophages (phages) are viruses that infect bacteria and are their natural predators. Like most viruses in nature, phages evolve to kill their host by binding them specifically […]

  • The Antibiotic Resistance Crisis

    The Antibiotic Resistance Crisis

    While COVID-19 is adversely impacting humanity, the next pandemic is knocking on our door, threatening to upend our lives and devastate our economies. In the pre-antibiotic era, death and human suffering were enormous as a result of today’s minor inconveniences as strep throat, ear infections, or minor surgery. However, with the growing threat of Antimicrobial […]

  • The Broken Antibiotic Market

    The Broken Antibiotic Market

    Huge unmet need – no incentives for new therapeutics As bacteria evolve, it’s only a matter of time before the bacteria will find a way to develop resistance to new anti-bacterial drugs. According to a 2021 WHO report, despite the growing awareness of the threat of antimicrobial resistance, the world is still failing to develop […]